Back to Browse Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 5

Rhinosinusitis in COPD: symptoms, mucosal changes, nasal lavage cells and eicosanoids

Authors Violetta M Piotrowska, Wojciech J Piotrowski, Zofia Kurmanowska, et al

Published 20 April 2010 Volume 2010:5 Pages 107—117

DOI http://dx.doi.org/10.2147/COPD.S8862

Review by Single-blind

Peer reviewer comments 3

Violetta M Piotrowska1, Wojciech J Piotrowski2, Zofia Kurmanowska2, Jerzy Marczak2, Paweł Górski2, Adam Antczak2

2Department of Pneumology and Allergy, Medical University of Lodz, Poland; 1Department of Pediatric Otolaryngology, Medical University of Lodz, Poland

Abstract: The coexistence of upper airways disease with chronic obstructive pulmonary disease (COPD) is not well documented. The aim of this research was to assess sino-nasal inflammation in COPD by various tools, and look for the impact on quality of life, relation to smoking, disease severity and systemic inflammation. Current and ex-smokers with COPD (n = 42) and healthy never-smokers (n = 21) were included in this study. COPD severity was assessed by GOLD criteria and BODE index. Markers of systemic inflammation were measured. Nasal symptoms and general quality of life were assessed using the questionnaires; sino-nasal questionnaire (SNAQ-11) and St. George's Respiratory Questionnaire (SGRQ). Nasal endoscopy and saccharine test were performed. Nasal lavages were collected for cytological examination and eicosanoids (cysteinyl leukotrienes, leukotriene B4, 8-isoprostane). Symptoms and endoscopic scores were higher in COPD (P ≤ 0.0001). Only SGRQ symptoms subscore correlated with SNAQ-11 (r = 0.34, P = 0.035). Mucociliary clearance was impaired only in current smokers (9.91 ± 0.49 versus 13.12 ± 0.68 minutes, P ≤ 0.001). 8-isoprostane was higher in COPD smokers compared to the controls (0.17 ± 0.04 versus 0.34 ± 0.09 pg/g protein, P < 0.05). Endoscopic score and mucociliary of impairment patients who currently smoked cigarettes correlated with concentrations of 8-isoprostane. None of the parameters correlated with disease severity and markers of systemic inflammation. We provide evidence of upper airways disease in COPD, which appears to be related more to patients who currently smoke than to disease severity.

Keywords: chronic obstructive pulmonary disease, eicosanoids, nasal lavage, rhinitis, smoking, upper airways disease

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

Erratum

Sørensen HT, Friborg S, Rungby J, Christiansen JS, Vaag A, Beck-Nielsen H

Clinical Epidemiology 2012, 4:49-50

Published Date: 20 December 2012

Comparison of different methods for detecting epidermal growth factor receptor mutations in peripheral blood and tumor tissue of non-small cell lung cancer as a predictor of response to gefitinib

Xu F, Wu J, Xue C, Zhao Y, Jiang W, Lin L, Wu X, Lu Y, Bai H, Xu J, Zhu G, Zhang L

OncoTargets and Therapy 2012, 5:439-447

Published Date: 12 December 2012

A validated disease specific prediction equation for resting metabolic rate in underweight patients with COPD

Anita Nordenson, Anne Marie Grönberg, Lena Hulthén, et al.

International Journal of Chronic Obstructive Pulmonary Disease 2010, 5:271-276

Published Date: 1 September 2010

Nebulized formoterol: a review of clinical efficacy and safety in COPD

Nicholas J Gross, James F Donohue

International Journal of Chronic Obstructive Pulmonary Disease 2010, 5:223-232

Published Date: 28 June 2010

Influencing the decline of lung function in COPD: use of pharmacotherapy

Ekaterina S Gladysheva, Atul Malhotra, Robert L Owens

International Journal of Chronic Obstructive Pulmonary Disease 2010, 5:153-164

Published Date: 17 May 2010

Development of the Lung Function Questionnaire (LFQ) to identify airflow obstruction

Barbara P Yawn, Douglas W Mapel, David M Mannino, et al

International Journal of Chronic Obstructive Pulmonary Disease 2010, 5:1-10

Published Date: 17 December 2009